CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer
Position
Chief Operating Officer
Company
Crispr Therapeutics
ZugBiotechnologyHealthcareHealth CareGeneticsTherapeuticsDescription
CRISPR Therapeutics has appointed Naimish Patel, M.D. as the new Chief Medical Officer, starting on May 28, to replace the former CMO. Additionally, Julianne Bruno has been promoted to the role of Chief Operating Officer.
Quick answer
CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer (May 24, 2024). Crispr Therapeutics is based in Zug, Zug, Switzerland.
- Who is the new Chief Operating Officer at Crispr Therapeutics?
- Crispr Therapeutics named Julianne Bruno Chief Operating Officer, announced May 24, 2024.
- What did Crispr Therapeutics announce on May 24, 2024?
- CRISPR Therapeutics has appointed Naimish Patel, M.D. as the new Chief Medical Officer, starting on May 28, to replace the former CMO. Additionally, Julianne Bruno has been promoted to the role of Chief Operating Officer.
- What does Crispr Therapeutics do?
- CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
- Where is Crispr Therapeutics based?
- Crispr Therapeutics is based in Zug, Zug, Switzerland.
- Which similar companies made leadership changes around the same time?
- Chroma Medicine (May 20, 2024), Crinetics Pharmaceuticals (May 30, 2024), Geneoscopy (May 15, 2024) and Wave Life Sciences (May 10, 2024) also announced leadership changes within 45 days of Crispr Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Genetics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer (May 20, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Geneoscopy Appoints Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations (May 15, 2024)
- Wave Life Sciences Appoints Erik Ingelsson as Chief Scientific Officer (May 10, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- QurAlis Appoints Doug Williamson and Jason Brown to Key Executive Positions (June 13, 2024)
Who to call at Crispr Therapeutics, and when
A new leader at Crispr Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Crispr Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crispr Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crispr Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crispr Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Crispr Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.